Applications of the cumulative rate to kidney cancer statistics in Australia by Brennan, Janelle et al.
Applications of the Cumulative Rate to Kidney
Cancer Statistics in Australia
Janelle Brennan1, K.C. Chan2, Rebecca Kippen3, C.T. Lenard4, T.M. Mills5,
and Ruth F.G. Williams4
1 Department of Urology, Bendigo Health, and St. Vincent’s Hospital Melbourne,
Australia
(E-mail: janellebrennan@gmail.com)
2 Computer Science and Information Technology, La Trobe University, Bendigo,
Australia
(E-mail: ka.chan@latrobe.edu.au)
3 School of Rural Health, Monash University, Bendigo, Australia
(E-mail: rebecca.kippen@monash.edu)
4 Mathematics and Statistics, La Trobe University, Bendigo, Australia
(E-mail: c.lenard@latrobe.edu.au)
5 Bendigo Health and La Trobe University, Bendigo, Australia
(E-mail: t.mills@latrobe.edu.au)
Abstract. Cancer incidence and mortality statistics in two populations are usually
compared by using either the age-standardised rate or the cumulative risk by a certain
age. We argue that the cumulative rate is a superior measure because it obviates the
need for a standard population, and is not open to misinterpretation as is the case for
cumulative risk. Then we illustrate the application of the cumulative rate by analysing
incidence and mortality data for kidney cancer in Australia using the cumulative
rate. Kidney cancer is also known as malignant neoplasm of kidney: we use the term
kidney cancer in this paper. Kidney cancer is one of the less common cancers in
Australia. In 2012, approximately 2.5% of all new cases of cancer were kidney cancer,
and approximately 2.1% of all cancer related deaths in Australia are due to kidney
cancer. There is variation in incidence and mortality by sex, age, and geographical
location in Australia. We examine how the cumulative rate performs in measuring
the variation of this disease across such subpopulations. This is part of our effort
to promote the use of the cumulative rate as an alternative to the age-standardised
rates or cumulative risk. In addition we hope that this statistical investigation will
contribute to the aetiology of the disease from an Australian perspective.
Keywords: Kidney cancer, Renal cell carcinoma, Incidence, Mortality, Cumulative
rate, Descriptive epidemiology.
1 Introduction
We define kidney cancer, which is also known as malignant neoplasm of kid-
ney, as the disease classified as C64 according to the International Statistical
Classification of Diseases and Related Health Problems, 10th Revision (ICD10)
by Australian Institute of Health and Welfare [1].
The incidence of kidney cancer is the number of new cases diagnosed each
year in a given region, in this case Australia. For each year, the mortality of
kidney cancer is the number of deaths for which the primary cause of death is
kidney cancer in Australia. Incidence and mortality are whole numbers.
The incidence of kidney cancer has been increasing worldwide (AB 2011, [5],
[6]. The reason for this is unknown, especially as there are marked geographic
variations, both within the same country and between countries [6]. Further
studies are necessary to improve the identification of risk factors that may lead
to cancer prevention.
Some of the increase in kidney cancer incidence has been attributed to the
increased use of diagnostic imaging with ultrasound, computerised tomogra-
phy and magnetic resonance imaging, resulting in increased detection of renal
cell carcinoma (RCC), and possibly downward stage migration. Overdetection
cannot entirely explain all of these variations, especially in Europe where there
exist variations within a single country with a national health care system [6].
In addition, the heterogeneity of kidney cancer incidence rates suggests the
existence of modifiable risk factors and potentially unknown genetic, infective,
dietary, environmental or behavioural factors that influence prevalence.
Stage migration has also been observed in the last 2–3 decades with more
localized tumours being found in the modern era. There is now uncertainty
regarding the optimal management of patients with small renal tumours, espe-
cially the elderly, with a greater emphasis on ablative or non-operative man-
agement [10]. Despite the frequent use of aggressive therapy, mortality rates
for elderly patients with kidney cancer in the USA have remained stagnant over
the past 25 years [9].
It is important for Australia to have an initial framework for understanding
the current state of kidney cancer in our society, and examination of the trends
in incidence, mortality and survival may allow the identification of modifiable
risk factors and also guide future workforce planning. A starting point is to
report the historical data, such as the Australian experience, to be able to see
patterns that may help our understanding of the epidemiological differences of
kidney cancer. This is particularly important given the increasing incidence
rate of kidney cancer with the associated increase in health care costs.
The aim of this paper is to compare the impact of kidney cancer on various
sub-populations in Australia through incidence and mortality statistics
There are two standard methods for making such comparisons. The first
is by using age-standardised rates, the second is to use cumulative risks. We
have reservations about both these methods.
Calculating age-standardised rates involves introducing an arbitrary, stan-
dard population. This allows us to compare the incidence rates in two popula-
tions that have different age structures. For example, the Australian Institute
of Health and Welfare (AIHW) [1] provides age-standardised rates based on
three, different, standard populations: the Australian 2001 population, the
Sergi world standard population, and the WHO standard population—and
these three rates are quite different from each other. For example, in 2012, the
three age-standardised incidence rates for kidney cancer are 12.4, 8.6, and 9.4
per 100,000 persons in Australia respectively. This is confusing for the general
reader.
Furthermore, if we want to compare the Australian incidence rate with the
incidence rate of another country, then we may have to re-calculate the rates
for at least one of the countries using a suitable standard population.
Finally, it is unlikely that, 100 years from now, we will still be using the
Australian 2001 population as a standard, and to make comparisons between
then and now will involve re-calculation.
The second standard method for making comparisons is based on the cu-
mulative risk by a certain age. For example, AIHW [1] reports that the risk
of being diagnosed with kidney cancer by age 75 in Australia is 1 in 101. This
measure is open to misunderstanding. The model on which the calculation of
this risk or probability is based on the assumption that the only cause of death
is kidney cancer. This has been pointed this out in [4, p. 443], [7] and the
underlying mathematical model has been explained in [8].
The age-standardised rate and the cumulative risk have the same inten-
tion: namely, to introduce a level playing field to facilitate comparing inci-
dence (or mortality) rates in populations with different age-structures. How-
ever, both methods involve introducing assumptions that are not correct. The
age-standardised rate is based on assuming that the populations have an age-
structure that they do not have. The cumulative risk is based on assuming
that the disease in question is the only cause of death.
The cumulative rate does not have these deficiencies. In this paper we com-
pare the incidence and mortality of kidney cancer for various sub-populations
in Australia using the cumulative rate.
2 Methods
Historical data on the incidence and mortality of kidney cancer were obtained
from Australian Institute of Health and Welfare [1]. These data sets contain
the incidence of kidney cancer for 1982–2012, the mortality for kidney cancer
for 1968–2013, and the population counts for those years. Data are stratified
by age group and sex.
The cumulative incidence rate by age 75 is calculated as follows.
Group Age group Population Incidence
1 [0, 4] n(1) x(1)
2 [5, 9] n(2) x(2)
...
...
...
...
k [5k − 5, 5k − 1] n(k) x(k)
...
...
...
...
15 [70, 74] n(15) x(15)
Table 1. Data for calculating cumulative rate by age 75
The cumulative incidence rate by age 75 is given as
a(75) = 5 ∗
k=15∑
k=1
(x(k)/n(k)) . (1)
The cumulative rate by age 75 is, essentially, the sum of the age-specific in-
cidence rates for each age from 0 to 75 (if we assume that the age-specific
incidence rate is constant throughout any particular age group). Notice that
this does not involve any arbitrary standardised population and it requires no
special assumptions as does the cumulative risk. Note that the cumulative rate
and the cumulative risk are approximately equal in value [8].
3 Results
Fig. 1. Incidence (1982–2012) and mortality (1968–2012) of kidney cancer in Aus-
tralia
Fig. 2. Cumulative incidence by age 75 of kidney cancer in Australia
Fig. 3. Cumulative mortality by age 75 of kidney cancer in Australia
Fig. 4. Cumulative incidence for various ages of kidney cancer in Australia over
several years
Fig. 5. Cumulative mortality for various ages of kidney cancer in Australia over
several years
4 Conclusions
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